BACKGROUND: Many reports of autoimmune hepatitis (AIH) were written in the 'pre-Hepatitis C era' and data on the natural history are still incomplete. AIM: To evaluate the clinical presentation and the natural history of type I AIH. METHODS: Seventy-three consecutive patients with a regular follow-up of at least 2 years were prospectively included in the study. The mean follow-up was 91 +/- 61 months. RESULTS: Patients with 'acute' onset at presentation were significantly older than patients with 'chronic' onset (P < 0.05) and had significantly higher serum levels of transaminase, gamma-glutamyltransferase and bilirubin; Prothrombin time was significantly lower in the said group compared with AIH patients with 'chronic' onset. In 4 of 63 (6...
BACKGROUND & AIMS: Changes in serum levels of transaminases immediately after initiation of treatmen...
Background and aims: Autoimmune hepatitis (AIH) is a rare indication (<5%) for liver transplantation...
International audienceBackground & aims: Autoimmune hepatitis (AIH) is a rare indication for liver t...
none10BACKGROUND: Autoimmune hepatitis (AIH) has three different presentations: chronic, acute and a...
Autoimmune Hepatitis (AIH) can present under clinical profile as acute hepatitis of unexplained caus...
Background & Aims: Patients with autoimmune hepatitis (AIH) can present with symptoms ranging from t...
Introduction and aim: Autoimmune hepatitis (AIH) may present acutely, which can rapidly progress to ...
Background /Aim : Autoimmune hepatitis (AIH) is a common cause of end-stage liver disease worldwide....
In general the prognosis of treated autoimmune hepatitis is comparable to the general population. Th...
Sven Francque1,2, Luisa Vonghia1,3, Albert Ramon1,4, Peter Michielsen1,21Antwerp University Hospital...
BACKGROUND & AIMS: Changes in serum levels of transaminases immediately after initiation of treatmen...
Background and aims: Autoimmune hepatitis (AIH) is a rare indication (<5%) for liver transplantation...
International audienceBackground & aims: Autoimmune hepatitis (AIH) is a rare indication for liver t...
none10BACKGROUND: Autoimmune hepatitis (AIH) has three different presentations: chronic, acute and a...
Autoimmune Hepatitis (AIH) can present under clinical profile as acute hepatitis of unexplained caus...
Background & Aims: Patients with autoimmune hepatitis (AIH) can present with symptoms ranging from t...
Introduction and aim: Autoimmune hepatitis (AIH) may present acutely, which can rapidly progress to ...
Background /Aim : Autoimmune hepatitis (AIH) is a common cause of end-stage liver disease worldwide....
In general the prognosis of treated autoimmune hepatitis is comparable to the general population. Th...
Sven Francque1,2, Luisa Vonghia1,3, Albert Ramon1,4, Peter Michielsen1,21Antwerp University Hospital...
BACKGROUND & AIMS: Changes in serum levels of transaminases immediately after initiation of treatmen...
Background and aims: Autoimmune hepatitis (AIH) is a rare indication (<5%) for liver transplantation...
International audienceBackground & aims: Autoimmune hepatitis (AIH) is a rare indication for liver t...